Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosis.

OBJECTIVES The aim of this study was to evaluate the anti-inflammatory properties of intermittent inhaled tobramycin. METHODS To establish this, we initiated a prospective study to measure the concentration of the three pro-inflammatory cytokines IL-8, IL-6 and TNF-alpha in the sputum from 20 cystic fibrosis (CF) patients (15 teenagers and 5 young adults) during cycles and off cycles. RESULTS A significant decrease in IL-8 (P = 0.001) and a more moderate decrease in IL-6 (P = 0.046) and TNF-alpha (P = 0.052) levels were observed during cycles, even if no significant decrease in the number of leucocytes was observed. CONCLUSIONS These results associated with a decrease in the Pseudomonas aeruginosa population can contribute in part to the beneficial effect of intermittent inhaled tobramycin on pulmonary function.

[1]  S. Cunningham,et al.  Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis , 2003, Pediatric pulmonology.

[2]  B. Ramsey,et al.  Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis. , 2002, Chest.

[3]  A. Quittner,et al.  Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection * † , 2002, Pediatric pulmonology.

[4]  M S Pepe,et al.  Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. , 1999, The New England journal of medicine.

[5]  A J Ratner,et al.  Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. , 1998, The Journal of clinical investigation.

[6]  M. Merten,et al.  Altered cytokine production by cystic fibrosis tracheal gland serous cells , 1997, Infection and immunity.

[7]  A. Prince,et al.  Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. , 1995, The Journal of clinical investigation.

[8]  B. Wretlind,et al.  TNF-alpha and IL-8 in consecutive sputum samples from cystic fibrosis patients during antibiotic treatment. , 2000, Scandinavian journal of infectious diseases.

[9]  A. Pukhalsky,et al.  Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. , 1999, Mediators of inflammation.